相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cell Model of Depression: Reduction of Cell Stress with Mirtazapine
Ana Salome Correia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Persimmon leaf extract alleviates chronic social defeat stress-induced depressive-like behaviors by preventing dendritic spine loss via inhibition of serotonin reuptake in mice
Hui Yu et al.
CHINESE MEDICINE (2022)
Farnesoid X Receptor-Mediated Cytoplasmic Translocation of CRTC2 Disrupts CREB-BDNF Signaling in Hippocampal CA1 and Leads to the Development of Depression-Like Behaviors in Mice
Wenfeng Hu et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2020)
Resveratrol Modulates the Gut-Brain Axis: Focus on Glucagon-Like Peptide-1, 5-HT, and Gut Microbiota
Ji Yeon Chung et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Glucagon-like peptide 1 (GLP-1)
T. D. Mueller et al.
MOLECULAR METABOLISM (2019)
Possible Role of Cyclic AMP Response Element Binding/Brain-Derived Neurotrophic Factor Signaling Pathway in Mediating the Pharmacological Effects of Duloxetine against Methamphetamine Use-Induced Cognitive Impairment and Withdrawal-Induced Anxiety and Depression in Rats
Sanaz Ramezany Yasuj et al.
ADVANCED BIOMEDICAL RESEARCH (2019)
Neuroprotective Effects of Sigesbeckia pubescens Extract on Glutamate-Induced Oxidative Stress in HT22 Cells via Downregulation of MAPK/caspase-3 Pathways
Md Rashedunnabi Akanda et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2018)
The Neuroprotective Effect of Curcumin Against Nicotine-Induced Neurotoxicity is Mediated by CREB-BDNF Signaling Pathway
Majid Motaghinejad et al.
NEUROCHEMICAL RESEARCH (2017)
Emerging Roles of CREB-Regulated Transcription Coactivators in Brain Physiology and Pathology
Carlos A. Saura et al.
TRENDS IN NEUROSCIENCES (2017)
Lifetime Duration of Depressive Disorders in Patients With Type 2 Diabetes
Mary de Groot et al.
DIABETES CARE (2016)
Depression in Type 2 Diabetes Mellitus: Prevalence, Impact, and Treatment
Katherine Semenkovich et al.
DRUGS (2015)
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Theo Vos et al.
LANCET (2015)
GLP-1 receptor agonist liraglutide reverses long-term atypical antipsychotic treatment associated behavioral depression and metabolic abnormalities in rats
Ajaykumar N. Sharma et al.
METABOLIC BRAIN DISEASE (2015)
NIDDK International Conference Report on Diabetes and Depression: Current Understanding and Future Directions
Richard I. G. Holt et al.
DIABETES CARE (2014)
The Economic Burden of Elevated Blood Glucose Levels in 2012: Diagnosed and Undiagnosed Diabetes, Gestational Diabetes Mellitus, and Prediabetes
Timothy M. Dall et al.
DIABETES CARE (2014)
The Mental Health Comorbidities of Diabetes
Lee Ducat et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Effects of antidepressants on glucose metabolism and diabetes mellitus type 2 in adults
Michael Deuschle
CURRENT OPINION IN PSYCHIATRY (2013)
Effects of diabetes on hippocampal neurogenesis: Links to cognition and depression
Nancy Ho et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
Cost-effectiveness of a Multicondition Collaborative Care Intervention
Joan Russo
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Psychological and quality of life changes in patients using GLP-1 analogues
Paul Grant et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2011)
Adult hippocampal neurogenesis buffers stress responses and depressive behaviour
Jason S. Snyder et al.
NATURE (2011)
The relationship between changes in depression symptoms and changes in health risk behaviors in patients with diabetes
Wayne J. Katon et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2010)
Hippocampal volume reduction and HPA-system activity in major depression
Michael Colla et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2007)
New approaches to antidepressant drug discovery: beyond monoamines
O Berton et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Global prevalence of diabetes - Estimates for the year 2000 and projections for 2030
S Wild et al.
DIABETES CARE (2004)